Tu HF - Search Results

1

Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model.

Hsu LC, Tu HF, Hsu FT, Yueh PF, Chiang IT. Hsu LC, et al. Among authors: tu hf. Biomed Pharmacother. 2020 Jun;126:110054. doi: 10.1016/j.biopha.2020.110054. Epub 2020 Mar 4. Biomed Pharmacother. 2020. PMID: 32145588 Free article.

2

Anticancer Efficacy and Mechanism of Amentoflavone for Sensitizing Oral Squamous Cell Carcinoma to Cisplatin.

Chen CH, Huang YC, Lee YH, Tan ZL, Tsai CJ, Chuang YC, Tu HF, Liu TC, Hsu FT. Chen CH, et al. Among authors: tu hf. Anticancer Res. 2020 Dec;40(12):6723-6732. doi: 10.21873/anticanres.14695. Epub 2020 Dec 7. Anticancer Res. 2020. PMID: 33288565

3

Regorafenib enhances antitumor immune efficacy of anti-PD-L1 immunotherapy on oral squamous cell carcinoma.

Chiang IT, Lee YH, Tan ZL, Hsu FT, Tu HF. Chiang IT, et al. Among authors: tu hf. Biomed Pharmacother. 2022 Mar;147:112661. doi: 10.1016/j.biopha.2022.112661. Epub 2022 Jan 26. Biomed Pharmacother. 2022. PMID: 35092865 Free article.

4

Imipramine Suppresses Tumor Growth and Induces Apoptosis in Oral Squamous Cell Carcinoma: Targeting Multiple Processes and Signaling Pathways.

Hsu LC, Lin CN, Hsu FT, Chen YT, Chang PL, Hsieh LL, Wang HY, Lin KH, Hsiao HC, Tu HF. Hsu LC, et al. Among authors: tu hf. Anticancer Res. 2023 Sep;43(9):3987-3996. doi: 10.21873/anticanres.16586. Anticancer Res. 2023. PMID: 37648317

5

EGF up-regulates miR-31 through the C/EBPβ signal cascade in oral carcinoma.

Lu WC, Kao SY, Yang CC, Tu HF, Wu CH, Chang KW, Lin SC. Lu WC, et al. Among authors: tu hf. PLoS One. 2014 Sep 17;9(9):e108049. doi: 10.1371/journal.pone.0108049. eCollection 2014. PLoS One. 2014. PMID: 25229239 Free PMC article.

6

miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.

Peng SY, Tu HF, Yang CC, Wu CH, Liu CJ, Chang KW, Lin SC. Peng SY, et al. Among authors: tu hf. Int J Cancer. 2018 Dec 1;143(11):2892-2904. doi: 10.1002/ijc.31638. Epub 2018 Oct 4. Int J Cancer. 2018. PMID: 29971778

7

Arecoline-regulated ataxia telangiectasia mutated expression level in oral cancer progression.

Tu HF, Chen MY, Lai JC, Chen YL, Wong YW, Yang CC, Chen HY, Hsia SM, Shih YH, Shieh TM. Tu HF, et al. Head Neck. 2019 Aug;41(8):2525-2537. doi: 10.1002/hed.25718. Epub 2019 Feb 28. Head Neck. 2019. PMID: 30821076

8

Establishment of syngeneic murine model for oral cancer therapy.

Chen YF, Chang KW, Yang IT, Tu HF, Lin SC. Chen YF, et al. Among authors: tu hf. Oral Oncol. 2019 Aug;95:194-201. doi: 10.1016/j.oraloncology.2019.06.026. Epub 2019 Jun 28. Oral Oncol. 2019. PMID: 31345390

9

Establishment of a p53 Null Murine Oral Carcinoma Cell Line and the Identification of Genetic Alterations Associated with This Carcinoma.

Chang KW, Lin CE, Tu HF, Chung HY, Chen YF, Lin SC. Chang KW, et al. Among authors: tu hf. Int J Mol Sci. 2020 Dec 8;21(24):9354. doi: 10.3390/ijms21249354. Int J Mol Sci. 2020. PMID: 33302499 Free PMC article.

10

Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.

Tu HF, Wu CH, Kao SY, Liu CJ, Liu TY, Lui MT. Tu HF, et al. J Oral Pathol Med. 2007 Aug;36(7):409-14. doi: 10.1111/j.1600-0714.2007.00552.x. J Oral Pathol Med. 2007. PMID: 17617834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters